The Changing Possibilities in Haemophilia® programme has three core ambitions, to;
- Strengthen understanding of haemophilia in the broader society
- Improve access to diagnosis, care and treatment
- Advance treatment and care through innovation
Strengthen understanding of haemophilia in the broader society
Working with representatives from across the haemophilia community we are continuously strengthening our understanding. This has resulted in the largest multi-country psychosocial survey conducted to date in haemophilia; HERO (Haemophilia Experiences, Results and Opportunities) provides new evidence of what it is like to live with haemophilia. Novo Nordisk has furthermore created the Buddy Award programme that allows people in the local haemophilia community to show their appreciation for those who support them. The Buddy Award celebrates the efforts of sisters, brothers, nurses, parents and best friends and the award ceremonies significantly increase the awareness levels in the local communities.
Improve access to diagnosis, expert care and treatment
We work to improve access to diagnosis, expert care and treatment primarily through our commitment to the Novo Nordisk Haemophilia Foundation (NNHF), focusing on capacity building, awareness creation as well as improving diagnosis and registries. The NNHF has an impact around the world supporting healthcare professionals and reaching out to people with haemophilia and allied bleeding disorders, their family members and other community members.
Advance treatment and care through innovation
Finally, we collaborate with patient and medical organisations around the world to advance treatment and care through innovation supporting education and advocacy and the development of new thinking. As an example, our Access to Insight programme supports global haemostasis research with grants, scholarships and awards.